Eugene Schneider - EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC

Issuer-level insider activity

Role
EVP, Chf Clinical Develop Ofcr
Issuer ticker
IONS on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Eugene Schneider in IONIS PHARMACEUTICALS INC

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-66,951
Avg price
$73.69
Total value
-$4,933,871

Net

Past year
Shares
-66,951
Share %
-100%
Total value
-$4,933,871

Reported holdings for Eugene Schneider in IONIS PHARMACEUTICALS INC

Form 4 holding EVP, Chf Clinical Develop Ofcr

IONIS PHARMACEUTICALS INC

Security class
Performance Restricted Stock Units
Shares / value
91,237
Estimated value
$2,148,297
Report date
15 Jan 2026
Price
$32.83
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, Chf Clinical Develop Ofcr

IONIS PHARMACEUTICALS INC

Security class
Restricted Stock Unit
Shares / value
48,926
Estimated value
$2,000,529
Report date
15 Jan 2026
Price
$32.83
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, Chf Clinical Develop Ofcr

IONIS PHARMACEUTICALS INC

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
26,000
Estimated value
Report date
26 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Eugene Schneider in IONIS PHARMACEUTICALS INC

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .